Floatz logo

Imiquimod

High-grade Squamous Intraepithelial Lesion

AIDS Malignancy ConsortiumSmall moleculePhase 3Dormant
B
63/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
48/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the High-grade Squamous Intraepithelial Lesion cohort.

Asset / SponsorPhaseRating
FLUOROURACILUM
AIDS Malignancy Consortium
Phase 3BB

Same molecule, other indications

Imiquimod is also rated in:

lentigo maligna melanomaDormant
BBB
Indicative ·
77 / 100
View asset →
human papilloma virus infectionDormant
B
Indicative ·
63 / 100
View asset →
melanomaDormant
B
Indicative ·
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →